Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Cobro Ventures

Investor type Private Equity Firm
Founders Alain Cohen Marc Cohen

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 15
Average round size
info
The average size of a deal this fund participated in
$26M
Portfolio companies 10
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.27
Exits 4
Key employees 1
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Medical
  • Therapeutics
  • Health Care
  • Genetics
Summary

Opposing the other organizations, this Cobro Ventures works on 4 percentage points less the average amount of lead investments. The higher amount of exits for fund were in 2019. The real fund results show that this VC is 30 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2019. The fund is generally included in less than 2 deals every year. Deals in the range of 50 - 100 millions dollars are the general things for fund.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Cobro Ventures, startups are often financed by Korea Investment Partners, Emigrant Capital, U.S. Department of Defense. The meaningful sponsors for the fund in investment in the same round are Taiwania Capital, Korea Investment Partners, Emigrant Capital. In the next rounds fund is usually obtained by Taiwania Capital, U.S. Department of Defense, RTW Investments LLC.

The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight C4 Therapeutics, Frequency Therapeutics. We can highlight the next thriving fund investment areas, such as Genetics, Medical. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.

This organization was formed by Marc Cohen.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Cobro Ventures:
Typical Co-investors
Cobro Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Cobro Ventures:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Beijing Supertool Internet Technology Beijing, Beijing, China
CEWE Stiftung & Co. Germany, Mecklenburg-Vorpommern, Oldenburg
Junchenda Capital -
Lookout Capital North Carolina, Raleigh, United States
Merit Capital Partners Chicago, Illinois, United States
October France, Ile-de-France, Paris
OuDe Capital -
Shamrock Ventures, B.V. Cambridge, Massachusetts, United States
The Kita-Nippon Bank Iwate Prefecture, Japan, Morioka
Wolf Bay Holdings Seattle, United States, Washington

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

AI Proteins

Artificial Intelligence
Biotechnology
Therapeutics
$18M03 Nov 2022 Andover, Massachusetts, United States

Regenacy Pharmaceuticals

Biotechnology
Medical
Therapeutics
$9M15 Aug 2022 Massachusetts, United States

NextRNA Therapeutics

Biotechnology
Health Care
Therapeutics
$46M01 Mar 2022 Cambridge, Massachusetts, United States

Windgap Medical

Biotechnology
Health Care
Manufacturing
Medical
Medical Device
Pharmaceutical
$39M20 Jan 2022 Massachusetts, United States

TechsoMed

Biotechnology
Health Care
$7M03 Mar 2021 Israel, Tel Aviv District, Israel

Mana Therapeutics

Biotechnology
$35M08 Jan 2021 Arlington, Virginia, United States

Regenacy Pharmaceuticals

Biotechnology
Medical
Therapeutics
$30M25 Mar 2020 Massachusetts, United States

Frequency Therapeutics

Biotechnology
Genetics
Medical
$62M23 Jul 2019 Woburn, Massachusetts, United States

Frequency Therapeutics

Biotechnology
Genetics
Medical
$42M07 Jan 2019 Woburn, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Cobro Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: